Alere, Feds Reach $33.2M Deal In Medical Device FCA Suit

By Taylor Arluck (March 23, 2018, 4:53 PM EDT) -- Alere Inc. and the federal government reached a $33.2 million civil settlement in a whistleblower's Maryland federal court suit alleging the medical laboratory company submitted false claims to Medicare, Medicaid and Tricare for defective cardiac medical devices, the U.S. Department of Justice announced Friday.

Abbott Laboratories' Alere Inc. and its subsidiary Alere San Diego Inc. agreed to pay the federal government $33,239,672 to settle False Claims Act allegations that they sold unreliable Triage cardiac marker testing devices used to diagnose heart conditions in emergency rooms from January 2006 to March 2012. The federal government claimed the devices produced faulty test results...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!